E-viri
Recenzirano
Odprti dostop
-
Al‐Naamani, Nadine; Krowka, Michael J.; Forde, Kimberly A.; Krok, Karen L.; Feng, Rui; Heresi, Gustavo A.; Dweik, Raed A.; Bartolome, Sonja; Bull, Todd M.; Roberts, Kari E.; Austin, Eric D.; Hemnes, Anna R.; Patel, Mamta J.; Oh, Jae K.; Lin, Grace; Doyle, Margaret F.; Denver, Nina; Andrew, Ruth; MacLean, Margaret R.; Fallon, Michael B.; Kawut, Steven M.; Timmerman, Kasi; Mottram, C.D.; Scanlon, Paul D.; Miller, Adam; Visnaw, Karen; Homer, Natalie; Andrew, Ruth; Abbott, Cheryl; Palevsky, Harold I.; Rajender Reddy, K.; Goldberg, David S.; Khungar, Vandana; Akaya Smith, K.; Fritz, Jason S.; Lynch, Marita; Sharkoski, Tiffany; Pinder, Diane; Machicao, Victor; Rubin, Moises Nevah; Walker, Kim; Cranford, Stacy; Varing, Jordan; Banga, Namrata; Igenoza, Oluwatosin; LaRochelle, Celeste
Hepatology, February 2021, Letnik: 73, Številka: 2Journal Article
Background and Aims Portopulmonary hypertension (POPH) was previously associated with a single‐nucleotide polymorphism (SNP) rs7175922 in aromatase (cytochrome P450 family 19 subfamily A member 1 CYP19A1). We sought to determine whether genetic variants and metabolites in the estrogen signaling pathway are associated with POPH. Approach and Results We performed a multicenter case‐control study. POPH patients had mean pulmonary artery pressure >25 mm Hg, pulmonary vascular resistance >240 dyn‐sec/cm−5, and pulmonary artery wedge pressure ≤15 mm Hg without another cause of pulmonary hypertension. Controls had advanced liver disease, right ventricular (RV) systolic pressure <40 mm Hg, and normal RV function by echocardiography. We genotyped three SNPs in CYP19A1 and CYP1B1 using TaqMan and imputed SNPs in estrogen receptor 1 using genome‐wide markers. Estrogen metabolites were measured in blood and urine samples. There were 37 patients with POPH and 290 controls. Mean age was 57 years, and 36% were female. The risk allele A in rs7175922 (CYP19A1) was significantly associated with higher levels of estradiol (P = 0.02) and an increased risk of POPH (odds ratio OR, 2.36; 95% confidence interval CI, 1.12‐4.91; P = 0.02) whereas other SNPs were not. Lower urinary 2‐hydroxyestrogen/16‐α‐hydroxyestrone (OR per 1‐ln decrease = 2.04; 95% CI, 1.16‐3.57; P = 0.01), lower plasma levels of dehydroepiandrosterone‐sulfate (OR per 1‐ln decrease = 2.38; 95% CI, 1.56‐3.85; P < 0.001), and higher plasma levels of 16‐α‐hydroxyestradiol (OR per 1‐ln increase = 2.16; 95% CI, 1.61‐2.98; P < 0.001) were associated with POPH. Conclusions Genetic variation in aromatase and changes in estrogen metabolites were associated with POPH.
Avtor
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|
Vir: Osebne bibliografije
in: SICRIS
To gradivo vam je dostopno v celotnem besedilu. Če kljub temu želite naročiti gradivo, kliknite gumb Nadaljuj.